USFDA classifies inspection of Cadila Healthcare’s Moraiya unit as OAI

07 Aug 2019 Evaluate

Cadila Healthcare has received a letter from the US Food and Drug Administration (USFDA) classifying the inspection conducted at the company's Moraiya facility located at Ahmedabad, Gujarat from April 22, 2019 to May 3, 2019 as 'Official Action Indicated' (OAI).

The company believes that this classification will not have any impact on the current supplies or revenues of this facility. The company is in the process of sending further updates of its corrective actions to the USFDA and remains hopeful of a positive outcome.

Cadila Healthcare operates in areas of active pharmaceutical ingredients (API) to formulations, and animal health products to cosmeceuticals.

Zydus Lifesciences Share Price

896.60 3.15 (0.35%)
28-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.15
Dr. Reddys Lab 1224.30
Cipla 1328.25
Zydus Lifesciences 896.60
Lupin 2121.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×